Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Health Promotion and Disease Prevention Research Centers, Panel A, Funding Opportunity Announcement (FOA) DP09-001

---
identifier: "/us/fr/E8-26242"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Health Promotion and Disease Prevention Research Centers, Panel A, Funding Opportunity Announcement (FOA) DP09-001"
title_number: 0
title_name: "Federal Register"
section_number: "E8-26242"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Health Promotion and Disease Prevention Research Centers, Panel A, Funding Opportunity Announcement (FOA) DP09-001"
positive_law: false
currency: "2008-11-04"
last_updated: "2008-11-04"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E8-26242"
document_type: "notice"
publication_date: "2008-11-04"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "73 FR 65607"
fr_volume: 73
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Health Promotion and Disease Prevention Research Centers, Panel A, Funding Opportunity Announcement (FOA) DP09-001

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting.

*Time and Date:* 9 a.m.-5 p.m., January 13, 2009 (Closed). 9 a.m.-5 p.m., January 14, 2009 (Closed).

*Place:* W Hotel, Atlanta Midtown, 188 14th Street, NE., Atlanta, GA 30361.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of “Health Promotion and Disease Prevention Research Centers, Panel A, FOA DP09-001.”

*Contact Person for More Information:* Christine J. Morrison, PhD, Health Scientist, Office of the Director, Office of the Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639-3098.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: October 27, 2008.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.